Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives Supporting Development in Europe

In 2008, the European Union introduced the Advanced Medicines Regulation aiming to improve regulation of advanced therapy medicinal products (ATMPs). We applied the ATMPs classification definitions in this Regulation to understand the link of this emerging group of medicinal products and the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Farkas, Andreas M., Mariz, Segundo, Stoyanova-Beninska, Violeta, Celis, Patrick, Vamvakas, Spiros, Larsson, Kristina, Sepodes, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432638/
https://www.ncbi.nlm.nih.gov/pubmed/28560211
http://dx.doi.org/10.3389/fmed.2017.00053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432638/
https://www.ncbi.nlm.nih.gov/pubmed/28560211
http://dx.doi.org/10.3389/fmed.2017.00053

Ejemplares similares